143 related articles for article (PubMed ID: 38661475)
1. Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine.
Gottlieb S; Rand JS; Anderson ST
J Feline Med Surg; 2024 Apr; 26(4):1098612X241232546. PubMed ID: 38661475
[TBL] [Abstract][Full Text] [Related]
2. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine.
Roomp K; Rand J
J Feline Med Surg; 2009 Aug; 11(8):668-82. PubMed ID: 19592286
[TBL] [Abstract][Full Text] [Related]
3. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
[TBL] [Abstract][Full Text] [Related]
4. In cats with newly diagnosed diabetes mellitus, use of a near-euglycemic management paradigm improves remission rate over a traditional paradigm.
Nack R; DeClue AE
Vet Q; 2014; 34(3):132-6. PubMed ID: 24964071
[TBL] [Abstract][Full Text] [Related]
5. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
Linari G; Fleeman L; Gilor C; Giacomelli L; Fracassi F
J Feline Med Surg; 2022 Feb; 24(2):168-176. PubMed ID: 34009061
[TBL] [Abstract][Full Text] [Related]
6. Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine.
Hall TD; Mahony O; Rozanski EA; Freeman LM
J Feline Med Surg; 2009 Feb; 11(2):125-30. PubMed ID: 18835801
[TBL] [Abstract][Full Text] [Related]
7. Treatment of 46 cats with porcine lente insulin--a prospective, multicentre study.
Michiels L; Reusch CE; Boari A; Petrie G; Mandigers P; Thollot IG; Rosenberg D; Mooney C; Bonfanti U; Font A; Sparkes A; Bewig K; Clercx C; Jensen AL; Horspool LJ
J Feline Med Surg; 2008 Oct; 10(5):439-51. PubMed ID: 18619886
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.
Roomp K; Rand J
J Feline Med Surg; 2012 Aug; 14(8):566-72. PubMed ID: 22553309
[TBL] [Abstract][Full Text] [Related]
9. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.
Riederer A; Zini E; Salesov E; Fracassi F; Padrutt I; Macha K; Stöckle TM; Lutz TA; Reusch CE
J Vet Intern Med; 2016; 30(1):92-100. PubMed ID: 26700409
[TBL] [Abstract][Full Text] [Related]
11. Practical use of home blood glucose monitoring in feline diabetics.
Ford SL; Lynch H
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):283-301. PubMed ID: 23522173
[TBL] [Abstract][Full Text] [Related]
12. Feline diabetes mellitus: diagnosis, treatment, and monitoring.
Rios L; Ward C
Compend Contin Educ Vet; 2008 Dec; 30(12):626-39; quiz 639-40. PubMed ID: 19140103
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of long-term home monitoring of blood glucose concentrations in cats with diabetes mellitus: 26 cases (1999-2002).
Kley S; Casella M; Reusch CE
J Am Vet Med Assoc; 2004 Jul; 225(2):261-6. PubMed ID: 15323384
[TBL] [Abstract][Full Text] [Related]
14. Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release.
Krämer AL; Riederer A; Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Lutz TA; Contiero B; Zini E; Reusch CE
J Vet Intern Med; 2020 Nov; 34(6):2287-2295. PubMed ID: 33001499
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus.
Scuderi MA; Ribeiro Petito M; Unniappan S; Waldner C; Mehain S; McMillian CJ; Snead EC
Domest Anim Endocrinol; 2018 Oct; 65():80-89. PubMed ID: 30015124
[TBL] [Abstract][Full Text] [Related]
16. Use of glargine and lente insulins in cats with diabetes mellitus.
Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
[TBL] [Abstract][Full Text] [Related]
17. Remission in cats: including predictors and risk factors.
Gottlieb S; Rand JS
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):245-9. PubMed ID: 23522170
[TBL] [Abstract][Full Text] [Related]
18. Rebound hyperglycaemia in diabetic cats.
Roomp K; Rand J
J Feline Med Surg; 2016 Aug; 18(8):587-96. PubMed ID: 26045481
[TBL] [Abstract][Full Text] [Related]
19. Priorities on treatment and monitoring of diabetic cats from the owners' points of view.
Albuquerque CS; Bauman BL; Rzeznitzeck J; Caney SM; Gunn-Moore DA
J Feline Med Surg; 2020 Jun; 22(6):506-513. PubMed ID: 31241424
[TBL] [Abstract][Full Text] [Related]
20. Acceptance of home blood glucose monitoring by owners of recently diagnosed diabetic cats and impact on quality of life changes in cat and owner.
Hazuchova K; Gostelow R; Scudder C; Forcada Y; Church DB; Niessen SJ
J Feline Med Surg; 2018 Aug; 20(8):711-720. PubMed ID: 28911254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
